SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059594
Filing Date
2024-05-14
Accepted
2024-05-14 16:20:22
Documents
69
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20240331.htm   iXBRL 10-Q 1361090
2 EX-31.1 scph-ex31_1.htm EX-31.1 13620
3 EX-31.2 scph-ex31_2.htm EX-31.2 13088
4 EX-32.1 scph-ex32_1.htm EX-32.1 10789
5 EX-32.2 scph-ex32_2.htm EX-32.2 10143
  Complete submission text file 0000950170-24-059594.txt   7119374

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scph-20240331.xsd EX-101.SCH 1107547
73 EXTRACTED XBRL INSTANCE DOCUMENT scph-20240331_htm.xml XML 1279900
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 24944673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)